Pfizer Seeks Input On FDA/NIH Pediatric List After Zithromax Is Slated For Study
Executive Summary
FDA and the National Institute of Child Health & Human Development should seek sponsor input in compiling a list of off-patent drugs for which pediatric studies are needed, a Pfizer exec said Feb. 25